In the present study, the apoptotic effect of pycnogenol and its molecular mechanism in human oral squamous cell carcinoma HSC 3 cells were investigated. Pycnogenol significantly inhibited the viability of HSC 3 cells and suppressed neoplastic cell transfor mation in HSC 3 cells and TPA treated JB6 cells. It caused caspase dependent apoptosis evidenced by the increase in cleaved poly (ADP ribose) polymerase and caspase 3 in a dose dependent manner. Pycnogenol increased Bak protein by enhancing its pro tein stability whereas other Bcl 2 family members were not altered. In addition, the treatment with pycnogenol led to the production of reactive oxygen species and N acetyl L cysteine almost blocked pycnogenol induced reactive oxygen species generation. Taken together, these findings suggest that pycnogenol may be a poten tial candidate for the chemoprevention or chemotherapy of human oral cancer.
Introduction O ral squamous cell carcinoma (OSCC) is one of the most common cancers, with more than 2,800 new cases diagnosed in the Republic of Korea for 2011.
(1) Despite all the efforts of cancer biologists to improve cancer therapy, the 5-year survival rate for OSCC (approximately 45-50%) has not been greatly increased over the past two decades.
(2) Therefore, the discovery of anticancer drug candidates for the treatment of OSCC is still necessary and continues to pose a real challenge.
Apoptosis (programmed cell death) is a way of cell death that contributes to elimination of unnecessary and unwanted cells to maintain balance between cell survival and cell death. (3) It is mediated by two major pathways, the extrinsic pathway involving death receptors and the intrinsic pathway involving mitochondria. In particular, mitochondria-dependent apoptotic processes are mainly regulated by Bcl-2 family members including antiapoptotic proteins (Bcl-2, Bcl-xL, Mcl-1 and Bcl-w) and proapoptotic proteins (Bad, Bid, Bim, Bik, Bax, Bak, NOXA and PUMA). (4) Numerous studies have reported on the wide variety of natural products or their derivatives that have been used as sources for drug discovery for anticancer therapy.
(5-7) Pycnogenol is a natural plant extract obtained from the bark of the French maritime pine (Pinus maritima). The main constituents of pycnogenol are phenolic compounds, broadly divided into monomers and condensed flavonoids. (8) One of the most critical abilities of pycnogenol is to restore capillary endothelial integrity for anti-edema action in chronic disorders such as chronic venous insufficiency (CVI). (9) In spite of several studies that have reported that pycnogenol has anticancer activities, (10, 11) little has been discovered yet relating to human cancer yet.
In this study, we sought to elucidate the effect of pycnogenol in the human OSCC HSC-3 cell line and to delineate its activityassociated molecular mechanism.
Materials and Methods
Cell culture and chemical treatment. Human oral squamous cell carcinoma cell line, HSC-3 was kindly provided by Prof. Shindo (Hokkaido University, Hokkaido, Japan). Cells were cultured in DMEM (WelGENE Inc., Dae-gu, Korea) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin and streptomycin at 37°C in a 5% CO 2 incubator. The cells were treated with dimethyl sulfoxide (DMSO) or various doses (8, 16, 24 and 32 μg/ml) of pycnogenol (Carbosynth Ltd.; Compton, Berkshire, UK) for 24 h. Final concentration of DMSO did not exceed 0.1%.
Trypan blue exclusion assay. The growth-inhibitory effect of pycnogenol was determined with trypan blue solution (Gibco, Paisley, UK). Cells stained with trypan blue (0.4%) were counted using a hemocytometer. Each experiment was carried out in triplicate and the results were expressed as the mean ± SD for each treatment group.
3 (4,5 Dimethylthiazol 2 yl) 5 (3 carboxymethoxyphenyl) 2 (4 sulfophenyl) 2H tetrazolium (MTS) assay. Cell viability was determined by MTS assay (Promega, Madison, WI). Cells were seeded in 96-well plates and incubated with pycnogenol for 24 h. Briefly, MTS solution was added to each well and maintained for 1 h at 37°C. The absorbance was measured at 482 nm using a Chameleon microplate reader (Hidex, Turku, Finland). The data were expressed as the percentage of cell viability compared to the vehicle control.
Anchorage independent cell transformation assay (Soft agar assay). The effect of pycnogenol on neoplastic cell transformation was determined in JB6 or HSC-3 cells. 12-Otetradecanoylphorbol-13-acetate (TPA; Sigma-Aldrich Chemical Co., St. Louis, MO)-stimulated JB6 or HSC-3 cells were treated with pycnogenol and then incubated in 1 ml of 0.3% basal medium Eagle's agar containing 10% FBS. Cultures were maintained at 37°C in a 5% CO 2 incubator for 12 days (JB6) or 10 days (HSC-3).
After that, the cell colonies were counted.
Western blot analysis. , and the resultant cDNA was subjected to PCR using HiPi PCR PreMix (Elpis Biotech). The primer sequences were used: Bak sense 5'-CTG CCC TCT GCT TCT GAG GA-3', Bak antisense 5'-CTG TCA GGA TGG GAC CAT TG-3', GAPDH sense 5'-CGG AGT CAA CGG ATT TGG TCG TAT-3' and GAPDH antisense 5'-AGC CTT CTC CAT GGT GGT GAA GAC-3'. The PCR condition of Bak was as follows: 32 cycles: 1 min at 94°C, 1 min at 62°C, and 1 min at 72°C, and the PCR condition of GAPDH was as follows: 28 cycles: 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C. The intensities of each band were normalized to β-actin. The amplified products were analyzed by 2% agarose gel electrophoresis and stained with ethidium bromide.
Reactive oxygen species (ROS) assay. Cells were seeded on 4-well culture plate and treated with DMSO or pycnogenol (8, 16, 24 and 32 μg/ml). N-Acetyl-L-cysteine (NAC) was from Sigma-Aldrich Chemical Co (St. Louis, MO). After 24 h, cells were washed twice with PBS and 20 μM of 2',7'-Dichlorofluorescin Diacetate (DCFH-DA, Calbiochem, San Diego, CA) was added to cells in 4-well culture plate for 30 min at 5% CO 2 incubator and the cells were then visualized using a fluorescence microscope.
Statistical analysis. Student's t test was used to determine the significance of differences between the control and treatment groups; Values of p<0.05 were considered significant.
Results
Pycnogenol decreases cell viability and suppresses anchorage independent colony formation in HSC 3 human oral squamous cell carcinoma (OSCC) cells. In order to observe the effect of pycnogenol on the cell viability of HSC-3 cells, HSC-3 cells were treated with pycnogenol for 24 h and cell viability was determined by trypan blue exclusion assay and MTS assay. The results showed that pycnogenol caused a statistically significant decrease when used at concentrations of 16, 24 and 32 μg/ml (24 h) in both assays (Fig. 1) . The IC 50 value was found to be approximately 20 μg/ml at 24 h. To investigate the inhibitory effects of pycnogenol on neoplastic cell transformation, we performed a soft agar assay in TPA-treated JB6 cells and HSC-3 cells. Pycnogenol dramatically suppressed the TPA-induced anchorage-independent cell transformation of JB6 cells ( Fig. 2A and B) even though the doses of pycnogenol used (2.5 and 5 µg/ml) did not affect the viability in JB6 cells (Fig. 2C) . We also found that the number and size of colonies were considerably fewer and smaller when HSC-3 cells were treated with pycnogenol in a dosedependent manner (Fig. 2D) . These results suggest that pycnogenol may inhibit cell viability and attenuate neoplastic cell transformation in oral cancer.
Pycnogenol causes caspase dependent apoptosis in HSC 3
cells. To determine if the growth-inhibitory activity of pycnogenol might be due to apoptotic cell death, we investigated the apoptotic effects of pycnogenol by carrying out western blot analysis using antibodies against cleaved PARP and cleaved caspase 3. As shown in Fig. 3A , a dose-dependent increase in the expression levels of these proteins was seen in pycnogenol-treated HSC-3 cells. In order to confirm the necessity of caspase3 activity during apoptosis in this cell line, we used Z-VAD-FMK, a pancaspase inhibitor. The result showed that the apoptosis induced by pycnogenol was completely inhibited by Z-VAD-FMK (Fig. 3B) . Taken together, we conclude that pycnogenol can effectively lead to caspase-dependent apoptosis in HSC-3 cells.
Pycnogenol increases the expression level of Bak protein via post translational modification. To elucidate the molecular mechanism of pycnogenol-mediated apoptosis, we investigated whether Bcl-2 family proteins might be involved in its apoptotic activity. The results showed that pycnogenol considerably increased the expression level of Bak protein in a dosedependent manner (Fig. 4A and B) whereas expression of other Bcl-2 family proteins including Bax, Bad, Bcl-xL and Mcl-1 was not regulated (Fig. 4E) . Next, we performed RT-PCR for the purpose of identifying how pycnogenol regulates Bak protein in HSC-3 cells. As shown in Fig. 4C , pycnogenol did not alter the Bak mRNA levels suggesting that it may not regulate Bak protein at a transcriptional level. Thus, we examined protein stability of Bak using cycloheximide (CHX), a protein synthesis inhibitor. The results showed that co-treatment of pycnogenol and CHX significantly increased Bak protein levels while CHX treatment only caused a slight decrease in Bak protein expression (Fig. 4D) . Overall, pycnogenol can increase the level of Bak protein through augmenting its protein stability.
Pycnogenol induces ROS generation. A previous study reported that ROS generation might be involved in natural products-derived apoptosis in human oral cancer cell lines. (12) To validate the involvement of ROS in pycnogenol-mediated apoptosis, we performed a DCFH-DA assay in HSC-3 cells using Fig. 1 . Pycnogenol inhibits cell viability in the human OSCC HSC 3 cell line. HSC 3 cells were treated with DMSO or various doses (2.5 or 5 µg/ml) of pycnogenol for 24 h. Cell viability was determined using a trypan blue exclusion assay (A) and an MTS assay (B). The graphs show the mean ± SD of three independent experiments and significance (p<0.05) compared with the control group is indicated (*). a fluorescence microscope. As compared with the control, ROSpositive cells in pycnogenol-treated group were significantly increased in a dose-dependent manner (Fig. 5) . To confirm the involvement of ROS production in pycnogenol-treated cells, NAC, a kind of ROS scavenger was used. As shown in Fig. 6 , ROS production was significantly suppressed by NAC in pycnogenol-treated HSC-3 cells suggesting that pycnogenol may be related to ROS generation.
Discussion
Natural products are developed for the treatment of common human diseases including cardiovascular diseases, inflammatory diseases and genetic disorders (13) suggesting that they can be attractive candidates for cancer drug discovery. Some earlier studies have reported that pycnogenol reduced talc-induced neoplastic transformation in human ovarian cell cultures and augmented apoptotic activity in human promyeloid leukemia HL-60 cells and mammary cancer MCF-7 cells. (8, 11, 14) These studies, along with a few others that support its anti-neoplastic activity, indicate that pycnogenol could possibly have anticancer activity. Thus, in the current study, we determined the viability of HSC-3 cells using a trypan blue exclusion assay and MTS assay and the results showed that pycnogenol clearly decreased cell viability at 24 h with an IC 50 value of 20 μg/ml. Huang et al. (11) (2005) demonstrated that pycnogenol also inhibited the growth of HL-60, U937 and K562 human leukemia cells with IC 50 values at 24 h of 150, 40 and 100 μg/ml, respectively. The difference in IC 50 values suggests that human oral cancer cells might be more sensitive to pycnogenol than human leukemia cells. It was also reported that pycnogenol was proven to be a potent chemopreventive agent as evidenced by its ability to suppress neoplastic cell transformation. (8) Because the inhibition of the ability of cells to grow on soft agar is a characteristic of promising anticancer drug candidates, the study determined whether pycnogenol would be able to inhibit neoplastic cell transformation. The results showed that pycnogenol significantly reduced survival of cell suspended in soft agar, findings that were consistent with those of other previous study. (8) Apoptosis was also detected in HSC-3 cells treated with pycnogenol as evidenced by the cleavage of PARP and caspase 3. Several studies also found that pycnogenol induces differentiation and apoptosis in MCF-7 cells and HL-60 cells (11, 14) indicating that it can be a potent apoptotic inducer in human cancer cell lines. In the previous study, we reported that pycnogenol exerted caspase-independent apoptosis in MC-3 human mucoepidermoid carcinoma cell line by inducing nuclear translocation of apoptosisinducing factor.
(15) Thus, we investigated whether pycnogenolinduced apoptosis in HSC-3 cells is caspase 3-dependent and results showed that caspase 3 is deeply involved in its apoptotic activity unlike our previous results meaning that caspasedependency of pycnogenol is cell line-dependent. Based on these data, pycnogenol may be a good anticancer drug candidate against oral cancer.
Although we demonstrated that pycnogenol has anticancer effect in the human OSCC cell line, its molecular mechanism was not previously well understood. Bcl-2 family proteins are known to control the release of cytochrome c, resulting in mitochondriadependent apoptotic cell death.
(16) Therefore, we examined the possibility that Bcl-2 family proteins were involved in the molecular mechanism associated with pycnogenol-mediated apoptosis in HSC-3 cells. Our results showed that pycnogenol increased only Bak protein while other Bcl-2 proteins were not affected in this in vitro system. Bak is constitutively expressed in the mitochondrial outer membrane and its conformational change and oligomerization occur in response to apoptotic stimuli. (17) Deficiency in Bak protein has been strongly correlated with the development of tumors and overexpression of Bak was found to induce apoptosis in various cancer cell lines. (18, 19) Numerous kinds of anticancer drugs function by up-regulating the expression levels of Bak protein and our previous study showed that Bak is a key molecule involved in apoptosis of human oral cancer cell lines following exposure to the extracts of certain natural productsderived apoptosis. (20, 21) These findings suggest that Bak protein may be a critical target molecule in oral cancer during its apoptotic action.
Reactive oxygen species (ROS) have already been shown to perform certain functions in the apoptotic process through the regulation of proapoptotic proteins like Bcl-2 family members. (22) It was reported that many natural products can mediate apoptosis by generating ROS and in this way exert their anticancer activities. (23) (24) (25) Recently, several studies have found that xanthorrhizol and goniothalamin caused apoptosis by inducing ROS in human oral cancer cell lines and DMBA-induced oral carcinogenesis suggesting that ROS can be an efficient mode of action for natural product-mediated apoptosis. (26, 27) Numerous studies have demonstrated that pycnogenol has antioxidant activities in human lung carcinoma cells, high glucose-treated renal tubular cells and cultured normal endothelial cells. (28) (29) (30) On the other hand, pycnogenol has been reported that it caused oxidative stress in human fibrosarcoma and Escherichia coli superoxide dismutase and catalase deficient mutant cells. (10, 31) It is still controversial whether pycnogenol is a pro-oxidant or an antioxidant. Our results showed that higher doses of pycnogenol clearly produced ROS in HSC-3 cells implying that pycnogenol may be a pro-oxidant in HSC-3 human oral squamous carcinoma cells. Gandin et al. (29) have previously suggested that selenium at low concentrations may have antioxidant properties and at moderate to high concentrations have powerful pro-oxidant effects meaning that biological effects of selenium could be concentration-dependent. Yen et al. (32) reported that the phenolic compounds such as morin, naringenin and quercetin at higher concentration were highly cytotoxic because of their stimulation of oxidative stress even though they also have antioxidant activities. It suggests that pro-oxidant action of pycnogenol like other plant polyphenols might be a critical mechanism of its anticancer potential.
In conclusion, this study shows for the first time that pycnogenol suppresses neoplastic transformation and induces caspasedependent apoptosis in human OSCC HSC-3 cells. This phenomenon may be due to posttranslational modification of Bak protein and ROS generation. On the basis of these findings, we conclude that pycnogenol may be a potent candidate for chemoprevention or chemotherapy of oral cancer. 
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